Lomitapide
Product Specifications
Background
Lomitapide is a potent (IC50 = 8 nM) inhibitor of microsomal triglyceride transfer protein (MTP or MTTP) and is clinically useful in treating familial hypercholesterolemia.1,2 It has displayed anticancer activity acting through various pathways including autophagy-dependent cancer cell death via direct inhibition of the kinase activity of mTORC13, activation of AMPK/Beclin1-mediated autophagy4, Notch inhibition via targeting TACE and γ-secretase5, blocking ZDHHC5-dependent palmitoylation on SSTR56, PFKFB3 inhibition7, and PARP14/DRP1-mediated mitophagy8.
Conjugation
Unconjugated
Buffer
White solid
Storage Conditions
-20°C
Product Datasheet
https://www.biossantibodies.com/datasheets/bs-82975C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1072390-01 0.05 mg (E-Coli)
Recombinant Alkyl hydroperoxide reductase subunit C (ahpC)
Ask
View Details MBS1072390-02 0.2 mg (E-Coli)
Recombinant Alkyl hydroperoxide reductase subunit C (ahpC)
Ask
View Details 
MBS1072390-03 0.05 mg (Yeast)
Recombinant Alkyl hydroperoxide reductase subunit C (ahpC)
Ask
View Details MBS1072390-04 0.5 mg (E-Coli)
Recombinant Alkyl hydroperoxide reductase subunit C (ahpC)
Ask
View Details